XML 118 R90.htm IDEA: XBRL DOCUMENT
v3.23.3

Goodwill and Other Intangible Assets - Product Distribution Rights and Customer List (Details) $ in Millions | 1 Months Ended | 12 Months Ended
--- | --- | ---
Feb. 29, 2020 product item | Jun. 30, 2023 USD ($) | Jun. 30, 2022 USD ($)
Business Acquisition [Line Items] |  |  |
Impairment of intangible assets, finite-lived |  |  | $ 4.9
Consumer Health Segment |  |  |
Business Acquisition [Line Items] |  |  |
Impairment of intangible assets, finite-lived |  |  | $ 2.2
Innovus Pharmaceuticals, Inc |  |  |
Business Acquisition [Line Items] |  |  |
Number of products acquired | product | 35 |  |
Number of registered trademarks and or patent rights and customer lists acquired | item | 300 |  |
Innovus Pharmaceuticals, Inc | Consumer Health Segment |  |  |
Business Acquisition [Line Items] |  |  |
Impairment of intangible assets, finite-lived |  | $ 3.0 |

X
- Definition Number of Products Acquired + References No definition available. + Details
Name: | aytu_NumberOfProductsAcquired
Namespace Prefix: | aytu_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of Registered Trademarks and or Patent Rights and Customer Lists Acquired + References No definition available. + Details
Name: | aytu_NumberOfRegisteredTrademarksAndOrPatentRightsAndCustomerListsAcquired
Namespace Prefix: | aytu_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3 + Details
Name: | us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=aytu_ConsumerHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |